Humana (NYSE:HUM) Earns “Neutral” Rating from Cantor Fitzgerald

Humana (NYSE:HUM)‘s stock had its “neutral” rating reissued by equities researchers at Cantor Fitzgerald in a research report issued to clients and investors on Wednesday,Benzinga reports. They presently have a $290.00 price objective on the insurance provider’s stock. Cantor Fitzgerald’s price target indicates a potential upside of 14.66% from the stock’s previous close. Cantor Fitzgerald also issued estimates for Humana’s FY2025 earnings at $16.27 EPS.

HUM has been the subject of several other research reports. Truist Financial boosted their price objective on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. TD Cowen upped their price target on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Barclays raised their price objective on shares of Humana from $253.00 to $255.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 22nd. Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and boosted their target price for the stock from $247.00 to $308.00 in a research report on Wednesday, November 6th. Finally, Morgan Stanley reduced their price target on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a report on Wednesday. Nineteen research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $293.05.

Humana Stock Down 2.7 %

Shares of Humana stock opened at $252.92 on Wednesday. Humana has a 12-month low of $213.31 and a 12-month high of $406.46. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock has a 50 day moving average price of $272.44 and a two-hundred day moving average price of $295.47. The stock has a market capitalization of $30.45 billion, a P/E ratio of 22.40, a PEG ratio of 2.11 and a beta of 0.56.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.18% and a return on equity of 13.20%. Equities analysts expect that Humana will post 16.11 earnings per share for the current year.

Insider Activity

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 0.32% of the stock is owned by corporate insiders.

Institutional Trading of Humana

Large investors have recently added to or reduced their stakes in the company. FNY Investment Advisers LLC boosted its holdings in shares of Humana by 6,647.5% in the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock worth $6,916,000 after acquiring an additional 26,856 shares in the last quarter. Retirement Systems of Alabama boosted its stake in Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after purchasing an additional 192,801 shares in the last quarter. PDT Partners LLC grew its holdings in shares of Humana by 190.0% during the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock worth $1,286,000 after purchasing an additional 2,660 shares during the last quarter. Secure Asset Management LLC acquired a new stake in shares of Humana in the fourth quarter valued at $244,000. Finally, Ontario Teachers Pension Plan Board increased its stake in shares of Humana by 6.5% in the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after buying an additional 71,910 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.